Hypertrophic obstructive Cardiomyopathy
Conditions
Interventions
experimental group:Echocardiography-guided Radiofrequency ablation for Hypertrophic obstructive Cardiomyopathy (HOCM).
Sponsors
The First Affiliated Hospital of Air Force Medical
Eligibility
Sex/Gender
All
Age
No minimum to 100 Years
Inclusion criteria
Inclusion criteria: 1. Subject with quiescent condition or Intracardiac cavity of left ventricle after stimulation or Left Ventricle Outflow Tract Gradient >= 50 mmHg. 2. Subject with obvious clinical symptoms. 3. Subject with New York Heart Association (NYHA) cardiac function >= II grade. 4. Subject with adequate drug treatment is not effective or cannot tolerate side effects of the drug. 5. Subject was informed of the nature of the clinical study and agreed to participate in all the requirements of the clinical study, signed an informed consent form, and agreed to complete the following checks.
Exclusion criteria
Exclusion criteria: 1. Subject is pregnant, lactating, or planned to conceive during a clinical study. 2. Subject with Hypertrophic Non-obstructive Cardiomyopathy. 3. Subject with interventricular septal thickness >= 30mm. 4. Subject with Sudden Cardiac Death Index >= 10%. 5. Subject combined with other heart diseases requires surgical treatment. 6. Subject with heart failure(Defined as resting heart failure after intensive anti-heart failure therapy, left ventricular fraction of ejecting < 40%).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical and image index;MAE 30 days after operation; | — |
Countries
China
Contacts
Public ContactLiwen Liu
The First Affiliated Hospital of Air Force Medical
Outcome results
None listed